News Detail

Sweden, 11 April 2024: Drugs known as GLP-1 analogs have become increasingly popular to treat diabetes and obesity, but there have been concerns that they might increase the risk of thyroid cancer. Now an extensive Scandinavian study led by researchers at Karolinska Institutet ha......
View Details
Source : Karolinska Institutet
Cancer
Diabetes
Drugs
Thyroid
Thyroid Cancer
Agonist
Blood
Blood Sugar
GLP-1
Glucagon
Medicine
Obesity
Receptor
Research
Type 2 Diabetes
Related News
- New test enables doctors to anticipate a serious side effect of cancer therapy (17-03-2025)
- Chinese vaccine shows promise in stopping plaque build-up in arteries (15-03-2025)
- Researchers develop technique for storing life-saving drugs without temperature control (15-03-2025)
- NIT researchers develop eco-friendly process to remove pharmaceutical pollutants from wastewater (14-03-2025)
- New personalised vaccine shows promise in treating deadly pancreatic cancer (13-03-2025)
- Human body's protein recycling system fights bacteria like antibiotics: Study (06-03-2025)
- Researchers at IIT Kanpur Identify Crucial Drug Target Receptor for Treating Cancer and Respiratory Diseases (22-02-2025)
- Polymer coating designed to prevent blood clot formation on medical implants (21-02-2025)
- Repurposing amlodipine, could help manage ADHD symptoms: Study (20-02-2025)
- Fluoxetine promotes IL-10–dependent metabolic defenses to protect from sepsis-induced lethality (16-02-2025)